(NASDAQ: TLRY) Tilray Brands's forecast annual revenue growth rate of 4.66% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 35.91%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.06%.
Tilray Brands's revenue in 2026 is $837,323,000.On average, 14 Wall Street analysts forecast TLRY's revenue for 2026 to be $102,759,099,912, with the lowest TLRY revenue forecast at $96,981,521,948, and the highest TLRY revenue forecast at $109,169,310,430. On average, 13 Wall Street analysts forecast TLRY's revenue for 2027 to be $107,645,399,969, with the lowest TLRY revenue forecast at $100,190,122,414, and the highest TLRY revenue forecast at $114,369,014,091.
In 2028, TLRY is forecast to generate $111,546,051,517 in revenue, with the lowest revenue forecast at $104,835,253,155 and the highest revenue forecast at $116,093,316,448.